Piper Sandler Cuts Synopsys (NASDAQ:SNPS) Price Target to $653.00
Synopsys (NASDAQ:SNPS – Free Report) had its price target decreased by Piper Sandler from $655.00 to $653.00 in a report released on Thursday,Benzinga reports. Piper Sandler currently has an ...
Avalo Therapeutics (NASDAQ:AVTX) Now Covered by Piper Sandler
Piper Sandler began coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) in a research note issued on Friday, MarketBeat reports. The firm set an “overweight” rating and a $48.00 ...